About ATH
A clinical-stage biotechnology company developing treatments for neurodegenerative conditions including Parkinson's disease, Alzheimer's disease, and Huntington's disease.
All News for ATH
No news articles found for ATH yet.
A clinical-stage biotechnology company developing treatments for neurodegenerative conditions including Parkinson's disease, Alzheimer's disease, and Huntington's disease.
No news articles found for ATH yet.
Get alerts when news about ATH is published